Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Nick Day: Artemisinin combination therapy resistance

Professor Nicholas Day, Director of the Mahidol Oxford Tropical Medicine Research Unit in Thailand, talks about how malaria is becoming resistant to artemisinin, the drug that is currently most succesful in treating the disease.

Nick Day

Director of the Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand, Professor Nick Day is particularly interested in the epidemiology, pathophysiology and treatment of malaria, melioidosis, leptospirosis, rickettsial infections, Staphylococcus aureus infections, influenza, Dengue and other communicable diseases afflicting rural populations throughout Asia and beyond.

Outreach podcasts

Understanding great research doesn't have to be confusing. In this series of podcasts, our researchers explain what they get up to for a general audience.